TrialAmerican journal of hematology2011

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.

Shaji K Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.